www.sciencedirect.com/science/arti... - we used an AMS approach to operationalise & formalise a structured approach to FMT @imperialcollegeldn.bsky.social @imperialnhs.bsky.social

Current practices in OPAT programmes: 🌍 multi-centre survey - variation exists - need to understand differences to drive improvement @raseaton66.bsky.social @bsacandjac.bsky.social @conorjamieson.bsky.social academic.oup.com/jacamr/artic...

Stability of tigecycline in elastomeric devices for OPAT - Tigecycline meets the 🇬🇧 YCD criteria of ≤5% degradation limit. Fantastic collaboration with 🌍 colleagues @bsacandjac.bsky.social @raseaton66.bsky.social academic.oup.com/jacamr/artic...

Outpatient parenteral antimicrobial therapy significantly reduces cost of antimicrobial therapy compared to treatment in a hospital bed: doi.org/10.1093/jaca... @mgilchrist123.bsky.social @bsacandjac.bsky.social #JACAMRNews #OPAT #IDSky

Delighted to spend time talking (inter)national (C)OPAT strategies with @raseaton66.bsky.social @bsacandjac.bsky.social in my home town - workshops, conferences, working with new friends at SIDP, new GPRs coming, stability with Oz partners, opportunities, new connections-it will be an exciting year!

‘By standardising stability testing guidelines, we can broaden treatment options for patients with serious infections, improve clinical outcomes, advance antimicrobial stewardship, and reduce healthcare costs.’ @jac-amr.bsky.social @raseaton66.bsky.social @mgilchrist123.bsky.social

Check it out! BSAC's OPAT Conference 2024 has been featured on the ID:IOTS Podcast @idiots-pod.bsky.social! You can find the episode on Spotify - episode notes here: idiots.notion.site/94-BSAC-OPAT... @raseaton66.bsky.social

A quick reminder that the BSAC Winter Conference begins next week, 4-5 December! If you haven't booked your place yet, there's still time bsac.org.uk/infection2024/

🔥SNAP passed 3500🔥 Writing papers: Cefazolin (MSSA) and penicillin (PSSA) vs (flu)clox Recruiting: Adj clinda vs not (all) Adj cefazolin vs not (MRSA) Oral switch vs IV (all) Cefazolin +/- Erta/Placebo (MSSA) Dapto vs Vanco (MRSA) Coming "soon": Rifampin vs. none for PVIE (all) Ref: Dr.Lee #idsky

Is it time for global harmonization of OPAT drug stability testing frameworks? Great to collaborate with global colleagues from Australia and UK - still work to be done!